• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cardiol Res . Echocardiographic Characteristics of Subjects With COVID-19: A Case Series

tetano

Editor, Senior Moderator
Cardiol Res


. 2020 Aug;11(4):260-265.
doi: 10.14740/cr1084. Epub 2020 Jun 3.
Echocardiographic Characteristics of Subjects With COVID-19: A Case Series

Raymundo Vera-Pineda[SUP] 1 [/SUP], Edgar Francisco Carrizales-Sepulveda[SUP] 1 [/SUP], Adrian Camacho-Ortiz[SUP] 2 [/SUP], Laura Nuzzolo-Shihadeh[SUP] 2 [/SUP], Francisco Cruz-Ramos[SUP] 3 [/SUP], Alejandro Ordaz-Farias[SUP] 3 [/SUP], Mario Alberto Benavides-Gonzalez[SUP] 1 [/SUP], Gabriel Carranza-Villegas[SUP] 1 [/SUP]


AffiliationsExpand

Abstract

Although coronavirus disease 2019 (COVID-19) manifests in most cases with respiratory symptoms, other presentations can occur. Direct damage to the cardiovascular system has been reported and recently, acute myocardial injury has been identified as a risk factor for mortality. Transthoracic echocardiography is a non-invasive tool that allows the detection of myocardial damage with validated markers (left ventricular ejection fraction and global longitudinal strain). Herein, we present the echocardiographic findings in four patients with COVID-19. All cases had acute respiratory distress syndrome (100%). Three out of four had elevated levels of creatine kinase and creatine kinase myocardial band. One case had ventricular concentric remodeling (25%). All cases (100%) had altered ventricular function: two had a reduced ejection fraction (50%) and, of those available for global longitudinal strain analysis, all had abnormal global longitudinal strain (100%). One case was found to have a tricuspid vegetation of 12 ? 10 mm with no other manifestation of endocarditis. All of our cases had left ventricular dysfunction as assessed by echocardiography. One of our patients had a vegetation in the tricuspid valve. Two of our cases had a reduced ejection fraction. The importance of acute cardiac injury in COVID-19 has recently been established. A recent study found it to be an independent risk factor for mortality in patients with this disease. Information regarding echocardiographic characteristics of this population is scarce. Further research to elucidate the impact of these characteristics on morbidity and mortality is urgently needed.

Keywords: COVID-19; Heart failure; Transthoracic echocardiography.
 
Back
Top Bottom